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Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81A38Purpose: Previously, we identiﬁed the DIO2 gene as human OA sus-
ceptibility gene and showed detrimental DIO2 up-regulation in OA
affected cartilage. Additionally, we showed that pharmacological
inhibition of DIO2 signaling in a human 3D chondrogenesis cell-model
confers prolonged cartilage matrix homeostasis. Here we aim to inves-
tigate the beneﬁcial effect of deﬁcient deiodinase iodothyronine type-2
(DIO2) in OA by studying the effects of forced mechanical loading on in
vivo joint cartilage tissue homeostasis in Dio2 knockout mice.
Methods: Wild-type and C57BL/6-Dio2 -/- -mice were subjected to a
stringent, forced running regime for one hour per day for three weeks.
Severity of osteoarthritiswas assessed by histological scoring for cartilage
damage and synovitis. Genomewide gene expressionwas determined in
knee-cartilage bymicroarray analysis (IlluminaMouseWG-6 v2). STRING-
db analyses were applied to determine enrichment for speciﬁc pathways
and to visualize protein-protein interaction (PPI)-networks.
Results:Dio2-deﬁcientmice showed signiﬁcant less cartilage damage (P
< 0.0001) and reduced severity of synovitis (P ¼ 0.0184) after admin-
istration to a treadmill running model of OA. In the wild-type-speciﬁc
and the overall analyses we observed in total, 158 probes representing
147 unique genes signiﬁcantly differential expressed with a fold-change
 1.5 upon forced exercise. Among these are genes known for their
associationwith OA (e.g. Mef2c, Egfr, Ctgf, Prg4 and Ctnnb1), supporting
the use of forced running as an OA-model in mice. However, in the
knockout-speciﬁc analysis, we observed no signiﬁcant differential
expression in articular cartilage upon the running regime, suggesting an
attenuated response to biomechanical burden. Among the differential
expressed genes, thyroid signaling was found to interact directly with
the differential expressed genes through, Ctgf and Egfr, via thyroid
receptor alpha (Thra) and retinoid x receptor (Rxra). Dio2-deﬁcientmice
showed signiﬁcantly less cartilage damage and signs of synovitis.
Conclusions:We ﬁnd that Dio2 deﬁciency has a protective effect on the
homeostasis of articular cartilage in the knee-joints of mice undergoing
a forced running regime. This is consistent with our earlier ﬁndings,
showing that pharmacological inhibition of deiodinases in a human in
vitro chondrogenesis model has a beneﬁcial effect on the early for-
mation and maintenance of articular cartilage ECM. It is therefore
hypothesized that control of thyroid hormone signaling, both during
development and adult cartilage maintenance, is essential to ensure
normal bone and cartilage homeostasis, and that it could act as the
master-switch that forces maturational arrested chondrocytes to re-
activate the endochondral ossiﬁcation process, leading to articular
cartilage destruction. Our results show that interfering with intra-
cellular thyroid hormone levels could be a powerful way to oppose the
pathological events that are occurring in OA.
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SYNOVIAL MACROPHAGES PROMOTE TGF-b SIGNALING AFTER
INTRA-ARTICULAR INJECTIONS OF OXIDIZED LDL IN NAÏVE
MURINE KNEE JOINTS, PREVENTING PRODUCTION OF PRO-
INFLAMMATORY FACTORS S100A8/9, CHEMOKINES AND
AGGRECANASE-INDUCED NEO-EPITOPES
W. de Munter y, A.B. Blom y, P.M. van der Kraan y, J. Roth z, T. Vogl z,
W.B. van den Berg y, P.L. van Lent y. yRadboud Univ. Med. Ctr., Nijmegen,
Netherlands; z Inst. of Immunology, Muenster, Germany
Purpose: In previous studies we found that synovial macrophages
regulate joint pathology during experimental osteoarthritis (OA) and,
more recently, we found that high systemic levels of LDL aggravate joint
pathology during experimental OA with synovitis. LDL in inﬂamed
synovium is oxidized and taken-up by macrophages via scavenger
receptor A and CD36, leading to an activated macrophage phenotype. In
this study, we investigate whether direct injection of oxLDL into a
normal murine knee joint induces joint pathology and elucidate the role
of synovial macrophages in that process.
Methods: Knee joints of C57BL/6 mice were injected at ﬁve consecutive
days with 6 mL (1.2 mg/mL) oxLDL, LDL, or an equal volume of vehicle
(PBS). This same procedure was done in mice which were depleted of
synovialmacrophagesby intra-articular injectionof clodronate liposomes
seven days prior to the (ox)LDL or vehicle injections. Joint pathology was
investigated by immunohistochemistry and RNA expression and protein
production by synovium were determined using RT-PCR and luminex,
respectively. Active TGF-b was measured using a functional CAGA-luci-
ferase assay. Data are depicted as mean ± standard deviation.
Results: LDL and oxLDL injection in naïve knee joints did not increase
synovial thickening, or production of pro-inﬂammatory factors (IL-1b,IL-6 and S100A8/9) compared to vehicle injection. Levels of active TGF-b
in synovial wash-outs was, however, signiﬁcantly increased by 33%
(from 84.7 ng/mL/g synovium ± 14.4 to 113.0 ng/mL/g synovium ± 33.3;
p<0.05). Immunohistochemistry of total knee joints showed that oxLDL
injection decreased formation of aggrecanase-induced neo-epitopes
(NITEGE) compared with vehicle injections (3.6 times; p<0.05), espe-
cially in areas along the bone margins that are prone to develop
osteophytes (from arbitrary score 1.19 ± 0.57 to 0.33 ± 0.30; p<0.05).
In contrast, repeated injections of oxLDL in macrophage-depleted knee
joints led to a 3.1 fold increase of synovial thickening (due to cell inﬂux),
compared with injection of vehicle (p<0.01), while LDL injections did
not alter synovial thickening. Protein levels of S100A8/A9, markers for
inﬂammation, were signiﬁcantly increased in synovial wash-outs of
oxLDL injected joints, compared with LDL (fold increase 5.6; p<0.05) or
vehicle (fold increase 8.3; p<0.01) injection. RNA levels of chemokines
CCL2 (Mcp-1) and CCL3 (Mip-1a) were also signiﬁcantly upregulated
after oxLDL injections (6.7 fold and 4.6 fold, respectively; p<0.01). No
raise in active TGF-b was measured in macrophage-depleted joints.
NITEGE expression was markedly increased (fold increase 1.92) in the
synovial-cartilage contact areas after oxLDL injection (p<0.05).
Conclusions: Synovial macrophages promote anabolic effects after
oxLDL injections in knee joints, supporting earlier studies which show
increased ectopic bone formation during LDL-rich conditions in exper-
imental osteoarthritis. In absence of synovial macrophages, however,
oxLDL induces cell inﬂux, production of pro-inﬂammatorymediators and
aggrecanase activity, thereby increasing catabolic activity.
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CONDITIONAL DELETION OF CTGF REVEALS A PIVOTAL ROLE FOR
CTGF ON ACTIVATING THE LATENT COMPLEX OF TGFb
X. Tang, T. Vincent. Univ. of Oxford, Oxford, United Kingdom
Purpose: Work from our lab has identiﬁed an important role for the
pericellular matrix (PCM) of cartilage sequestering regulatory mole-
cules such as FGF2, latent TGFb and connective tissue growth factor
(CTGF). In rested cartilage these molecules are held back from the cell
surface, but upon mechanical stimulation they are released causing
cellular activation (Vincent et al. 2007, and unpublished results). Data
presented at OARSI 2014 revealed that CTGF and latent TGFb are
released in a high molecular weight complex upon cartilage injury. In
this study we extend these results to address how CTGF controls the
release and activation of latent TGFb.
Methods: CTGF ﬂoxed mice were crossed with ubiquitin Cre-ERT2 mice
to generate post natal, pan-tissue, tamoxifen-inducible CTGF knockout
mice. Femoral head avulsion of wild type or knockout tissue into serum
freemediumwas used as an injurymodel.Medium conditioned for up to
24hourswas analysed for CTGFandTGFbprotein, andphosphoSMAD2/3
activity. Selected cell surface receptors were blocked to assess their
involvement in activation of latent TGFb in the cut conditionedmedium.
Results: Medium conditioned by avulsion injury of CTGF knockout
murine cartilage conﬁrmed reduced levels of CTGF protein. Surpris-
ingly, levels of TGFb in the injury CMwas similar betweenwild type and
knockout tissues suggesting that CTGF was not required for the release
of latent TGFb from the pericellular matrix. However, injury CM gen-
erated from CTGF knockout cartilage showed reduced SMAD2/3 activity
in isolated porcine chondrocytes compared with activity from injured
wild type cartilage, indicating that CTGF is involved in the activation of
latent TGFb at the cell surface. Incubation of porcine chondrocytes with
either an RGD- integrin binding peptide or a blocker of LRP1 (scavenger
receptor which is known to internalise CTGF) did not affect SMAD2/3
activity in the injury medium suggesting that these known binding
partners of CTGF are unlikely to be involved in the CTGF-dependent
activation of latent TGFb.
Conclusions: Our results show CTGF has a critical role in activating
latent TGFb at the cell surface and is not required for the release of
latent TGFb from the pericellular matrix of cartilage upon injury.
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PHLPP1 DELETION INCREASES FGF18 EXPRESSION AND PROTECTS
AGAINST SURGICALLY-INDUCED OSTEOARTHRITIS
E.W. Bradley y, L.R. Carpio y, D.F. Amanatullah y, S. Kakar y, L.E. Ta y,
M.E. McGee-Lawrence z, A.C. Newton x, J.J. Westendorf y. yMayo Clinic,
Rochester, MN, United States; zGeorgia Regents Univ., Agusta, GA, United
States; xUniv. of California, San Diego, CA, United States
Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81 A39Purpose: Osteoarthritis (OA) is a degenerative joint disease and leading
cause of disability. Although Fgf18 is an emerging candidate, there are
no FDA-approved disease modifying OA drugs (DMOADs). We recently
identiﬁed the protein phosphatase Phlpp1 as an effector of chondrocyte
differentiation in vitro. Phlpp1 terminates Akt2 signaling but also
dephosphorylates and inactivates other substrates to arrest matrix
production and induce apoptosis. The purpose of this study was to
determine if Phlpp1 contributes to OA disease progression and inhibits
proper endochondral bone formation in humans and mice.
Methods: Phlpp1 Deﬁcient Mice: The Mayo Clinic Institutional Animal
Care and Use Committee approved all animal research.
Isolation, Culture, and Analysis of IMAC Cells: Immaturemouse articular
chondrocytes (IMACs) were collected from Phlpp1-/- or WT littermates.
Cultures were treated with 10 mM U0126 (Mek1/2 inhibitor), 0.1 mM
PD173074 (FgfR inhibitor), 5 mMNCS 117079 (Phlpp inhibitor) or DMSO.
Protein extracts were collected for Western blotting. Total RNA was
isolated and mRNA (2 mg) was reverse transcribed. The resulting cDNAs
were used to assay gene expression via real-time PCR.
DMMSurgeryandHistologicalAssessments:OAwassurgically inducedby
destabilizing the medial meniscus (DMM) of the right hind limb in 12
week-old, male mice (n ¼ 7 WT, 7 Phlpp1-/-). Limbs were dissected 12
weeks after surgery, ﬁxed, decalciﬁed and parafﬁn embedded. Sections
were collected every 100 mM through the entire joint and Safranin O/Fast
Green staining was performed. Osteoarthritis Research Society Interna-
tional (OARSI) scores (p¼ 0.03)were assessedby three blinded reviewers.
Immunohistochemical Staining: Tibias from 5-day old Phlpp1-/- (n¼ 5)
or WT (n ¼ 5) littermates were ﬁxed, decalciﬁed, and parafﬁn embed-
ded. Surgically discarded, de-identiﬁed articular cartilage was collected
from patients undergoing joint arthroplasty for OA or a femoral neck
fracture (FNFx) repair. Immunohistochemical (IHC) staining was per-
formed with Phlpp1 antibodies or control IgG.
Statistical Analysis: Data are shown as the mean ± standard error of the
mean (SEM). p values were determined with the student's t-test.
Results: PHLPP1was highly expressed in human articular cartilage from
OA patients, but was undetectable by IHC in articular cartilage samples
from FNFx specimens (Fig 1A). To determine if Phlpp1 contributes to OA
progression, we evaluated the effects of Phlpp1 deﬁciency on OA pro-
gression in mice using the DMM model. Phlpp1-/- mice showed sig-
niﬁcant reductions in OARSI scores and subchondral bone thickening
(Fig 1B), suggesting that loss of Phlpp1 is protective against OA
progression.
To elucidate the mechanism of this protective effect, we examined the
effects of Phlpp1 deﬁciency during endochondral bone formation.
Phlpp1 null mice exhibit reduced bone mass and growth plate abnor-
malities, including increased chondrocyte proliferation and matrix
production. Furthermore, Phlpp1 deﬁciency promoted expression of
Fgf18 (Fig. 1C), a growth factor that facilitates chondrogenesis, chon-
drocyte proliferation and cartilage regeneration in surgically-induced
models of osteoarthritis. Erk1/2 activity and chondrocyte proliferation
were also elevated. Chemical inhibition of the Fgf18 receptor, FgfR3,
abrogated the increased Erk1/2 phosphorylation observed in Phlpp1
null chondrocytes. Furthermore, blocking the function of FgfR3 or Erk1/
2 suppressed proliferation induced by Phlpp1 deﬁciency. Phlpp inhib-
itors also augmented Erk1/2 phosphorylation, matrix content and Fgf18
production (Fig 1D&E).Figure 1(A) PHLPP1 IHC in human articular cartilage from patients
undergoing total joint arthroplasty for OA or FNFx. (B) OARSI scores from
DMM surgeries performed on WT or Phlpp1-/- mice. (C) Fgf18 expression
was determined in Phlpp1-/- cells by qPCR. (D-E) Fgf18 expression and
Alcain blue staining of WT micromasses treated with the Phlpp1 inhibitor
NCS117079. *p<0.05.Conclusions: We show that PHLPP1 is highly expressed in articular
cartilage from osteoarthritic joints but not in healthy articular cartilage.
Preliminary data suggest that this increased PHLPP1 expression in OA
human articular cartilage is due to CpG island demethylation of the
Phlpp1 promoter. Importantly, inactivation of the Phlpp1 gene pro-
tected against OA progression in a surgically induced mouse model.
Chondrocyte proliferation and cartilaginous matrix production are
enhanced in Phlpp1-/- mice as well as chondrocytes treated with Phlpp
inhibitors due to increased production of Fgf18 and consequent acti-
vation of Erk1/2 activity. These results demonstrate that suppression of
Phlpp1 expression and/or activity is protective against cartilage
degeneration. Phlpp1 therefore contributes to cartilage development
and OA progression and may be a therapeutic target for OA treatment.
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SYNOVIAL FLUID CONCENTRATION OF GREMLIN1 BUT NOT
FRIZZLED-RELATED PROTEIN IS INCREASED IN PATIENTS AFTER
ACUTE KNEE INJURY
L. Zhong y, J. Leijten y, J. Post y, S. Larsson z, M. Karperien y, A. Struglics z.
yDept. of Dev.al BioEngineering, Enschede, Netherlands; zDept. of Clinical
Sci. Lund, Lund, Sweden
Purpose: Degenerative joint diseases are characterized by a disturbance
in joint homeostasis, which is poorly understood at the molecular level.
Previously, we have identiﬁed the secreted WNT antagonists dickkopf 1
homolog (Xenopus laevis) (DKK1) and frizzled-related protein (FRZB)
and the BMP antagonists Gremlin1 (GREM1) as regulators of cartilage
homeostasis by preventing hypertrophic differentiation of articular
chondrocytes, consistent with their role in articular cartilage homeo-
stasis. In this study we tested the hypothesis that health status of the
joint is reﬂected by the expression levels of FRZB and GREM1 in synovial
ﬂuid. To test this hypothesis, we performed a cross sectional analysis of
synovial ﬂuid samples collected from patients with acute and chronic
knee injury and compared these with synovial ﬂuid samples from knee
healthy controls.
Methods: Synovial ﬂuid was aspirated (Lund University, Sweden) from
patients with acute (n¼106, mean age 30 years [range 17-57], 0-77 days
from injury) and chronic (n ¼ 50, mean age 38 years [18-70] 1-37 years
after injury) knee injuries, and from knee healthy subjects (n ¼ 8, mean
age 28 years [17-85]). Synovial ﬂuid concentrations of FRZB and GREM1
were determined using ELISA (FRZB, R&D system; GREM1, Bio-connect
diagnostics). Concentration of cartilage biomarkers in synovial ﬂuid;
ARGS-aggrecan (in-house), cartilage oligomeric matrix protein (COMP;
BioVendor) and collagen epitope C2C (IBEX), and proinﬂammatory
cytokines (IL-1b, IL-6, IL-8 and TNF-a; Meso Scale Discovery) were
analyzed by immunoassays. Mann-Whitney tests for group compar-
isons and Spearman’s rank test (rS) for correlation analysis was used.
Results: Synovial ﬂuid concentration of FRZB in the acute injury group
was no different from the level in the reference group (p ¼ 0.99), but
was 2-fold (based on median concentrations) higher than the level of
the chronic injury group (p ¼ 0.023) (Fig. 1a). Synovial ﬂuid concen-
trations of GREM1 in the acute and chronic injury groups were both
higher than the level of the reference group, 2-fold (p ¼ 0.003) and 1.8-
fold (p¼ 0.031), respectively (Fig. 1b); also, in these patients the GREM1
concentration was negatively correlated to time after injury (rS ¼
-0.224, p ¼ 0.005). The FRZB and GREM1 concentrations of the acute
and chronic injury groups were not inﬂuenced by gender (p ¼ 0.550, p
¼ 0.825) or by age (rS ¼-0.146, p ¼ 0.068; rS ¼ -0.137, p ¼ 0.089),
although, the FRZB concentration was signiﬁcantly decreased in knee
healthy subjects with age (rS¼ -0.833, p ¼ 0.005). In the acute and
chronic injury groups, there was no correlation between FRZB and
GREM1 concentrations in synovial ﬂuid (rS¼ 0.04, p¼ 0.585). Also, for a
portion of the acute injury group (n ¼ 52) synovial ﬂuid FRZB concen-
trationwere correlated with COMP levels (rS¼ 0.284, p¼ 0.041) but not
with other cartilage markers (C2C p ¼ 0.55, ARGS-aggrecan p ¼ 0.311)
nor with any cytokine levels (p> 0.05 for all cytokines); the synovial
ﬂuid GREM1 concentration did not correlated with any cartilage marker
nor with cytokine levels (p > 0.05 for all markers).
Conclusions: Compared to chronic injured knees, acute injured knees
have higher synovial ﬂuid concentrations of FRZB and GREM1. Their
levels were not inﬂuenced by gender or age, indicating that the differ-
ences of FRZB and GREM1 concentrations between acute and chronic
injured knee joints depend on differences in disease conditions. Per-
sistent synovial ﬂuid levels of FRZB in acute injured knee joints might be
a way for cells trying to protect the cartilage from degradation by
